PRETELL: PREvention of TELomere-related Complications After Lung

Clinical Trial Summary

To evaluate the safety and efficacy of Danzol in lung transplant recipients with short telomeres. Subjects with short telomeres recipient of lung transplant, will be randomized in the first month post-transplant to either placebo or Danazol (200mg bid) in a 2:1 ratio.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05404919` - Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates	Phase 2
Completed	`NCT03299504` - Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
Completed	`NCT00755781` - Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation	Phase 3
Recruiting	`NCT05547698` - A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation	N/A
Terminated	`NCT03207399` - Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment	Phase 4
Completed	`NCT03300882` - PREDICT Cytomegalovirus (CMV)
Recruiting	`NCT05101460` - An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
Completed	`NCT03150095` - Health Coaching to Improve Self-Management in Thoracic Transplant Candidates	N/A
Completed	`NCT04420195` - Envarsus XR in Lung Transplant	Phase 2
Recruiting	`NCT02235610` - Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation	N/A
Not yet recruiting	`NCT06066229` - Identification of Patient Important Outcomes in Lung Transplantation
Recruiting	`NCT04601818` - Planned Semi-Elective Lung Tx Study	N/A
Recruiting	`NCT03072589` - Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation	Phase 1
Completed	`NCT01963780` - International EXPAND Lung Pivotal Trial	N/A
Recruiting	`NCT05671887` - DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Completed	`NCT03987113` - Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
Recruiting	`NCT02748798` - Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders	Early Phase 1
Completed	`NCT03167528` - Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients	N/A
Active, not recruiting	`NCT04244734` - Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.	N/A
Active, not recruiting	`NCT01365429` - Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs	N/A

NCT number	NCT04807309
Study type	Interventional
Source	Brigham and Women's Hospital
Contact
Status	Withdrawn
Phase	Phase 1/Phase 2
Start date	January 1, 2021
Completion date	January 1, 2022

PRETELL: PREvention of TELomere-related Complications After Lung Transplant — PRETELL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms